18F-CP6A

N/A

Report date: 2025/11/28 15:16:39

Base Information

Drug Name18F-CP6A

Drug Alias Name18F-CP6A

ClassificationRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Fluorine > 18F +[4]

Mechanisms of ActionPositron-emission tomography enhancersSynuclein alpha binders

TargetsSynuclein alpha

Therapy Area/IndicationsSynucleinopathies

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesShenzhen Braegen Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Braegen Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsSynucleinopathies

Inactive IndicationsN/A

Other Information

ATC CodeN/A